Resverlogix Corp clinical-stage biotechnology company... Show more
Industry Biotechnology
A.I.dvisor tells us that RVXCF and TELIF have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RVXCF and TELIF's prices will move in lockstep.
| Ticker / NAME | Correlation To RVXCF | 1D Price Change % | ||
|---|---|---|---|---|
| RVXCF | 100% | N/A | ||
| TELIF - RVXCF | 22% Poorly correlated | +1.31% | ||
| GRCE - RVXCF | 21% Poorly correlated | +0.34% | ||
| FULC - RVXCF | 20% Poorly correlated | +1.97% | ||
| NEUP - RVXCF | 20% Poorly correlated | -3.92% | ||
| SQZB - RVXCF | 20% Poorly correlated | -6.67% | ||
More | ||||